These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31167728)

  • 1. Phosphoproteomics of Alzheimer disease brain: Insights into altered brain protein regulation of critical neuronal functions and their contributions to subsequent cognitive loss.
    Butterfield DA
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2031-2039. PubMed ID: 31167728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
    Butterfield DA
    Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.
    Triplett JC; Swomley AM; Cai J; Klein JB; Butterfield DA
    J Alzheimers Dis; 2016; 49(1):45-62. PubMed ID: 26444780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies.
    Sultana R; Butterfield DA
    J Alzheimers Dis; 2013; 33 Suppl 1():S243-51. PubMed ID: 22683528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics.
    Swomley AM; Butterfield DA
    Arch Toxicol; 2015 Oct; 89(10):1669-80. PubMed ID: 26126631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.
    Butterfield DA; Boyd-Kimball D
    J Neurochem; 2019 Nov; 151(4):459-487. PubMed ID: 30216447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.
    Barone E; Di Domenico F; Sultana R; Coccia R; Mancuso C; Perluigi M; Butterfield DA
    Free Radic Biol Med; 2012 Jun 1-15; 52(11-12):2292-301. PubMed ID: 22549002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.
    Butterfield DA; Boyd-Kimball D
    J Alzheimers Dis; 2018; 62(3):1345-1367. PubMed ID: 29562527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
    Aluise CD; Robinson RA; Cai J; Pierce WM; Markesbery WR; Butterfield DA
    J Alzheimers Dis; 2011; 23(2):257-69. PubMed ID: 20930294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 12. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment.
    Counts SE; Alldred MJ; Che S; Ginsberg SD; Mufson EJ
    Neuropharmacology; 2014 Apr; 79():172-9. PubMed ID: 24445080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the fluctuations of dynamic resting-state electrophysiological functional connectivity: reduced neuronal coupling variability in mild cognitive impairment and dementia due to Alzheimer's disease.
    Núñez P; Poza J; Gómez C; Rodríguez-González V; Hillebrand A; Tola-Arribas MA; Cano M; Hornero R
    J Neural Eng; 2019 Sep; 16(5):056030. PubMed ID: 31112938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.
    Aluise CD; Robinson RA; Beckett TL; Murphy MP; Cai J; Pierce WM; Markesbery WR; Butterfield DA
    Neurobiol Dis; 2010 Aug; 39(2):221-8. PubMed ID: 20399861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease.
    Keeney JT; Swomley AM; Harris JL; Fiorini A; Mitov MI; Perluigi M; Sultana R; Butterfield DA
    Neurotox Res; 2012 Oct; 22(3):220-30. PubMed ID: 22083458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
    Reed TT; Pierce WM; Markesbery WR; Butterfield DA
    Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulus-induced gamma rhythms are weaker in human elderly with mild cognitive impairment and Alzheimer's disease.
    Murty DV; Manikandan K; Kumar WS; Ramesh RG; Purokayastha S; Nagendra B; Ml A; Balakrishnan A; Javali M; Rao NP; Ray S
    Elife; 2021 Jun; 10():. PubMed ID: 34099103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.
    Yan L; Chen Y; Li W; Huang X; Badie H; Jian F; Huang T; Zhao Y; Cohen SN; Li L; Zhang YW; Luo H; Tu S; Xu H
    Sci Rep; 2016 Jan; 6():18668. PubMed ID: 26733416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COWAT Performance of Persons with Alzheimer Dementia, Vascular Dementia, and Parkinson Disease Dementia According to Stage of Cognitive Impairment.
    Lim KB; Kim J; Lee HJ; Yoo J; Kim HS; Kim C; Lee H
    PM R; 2019 Jul; 11(7):737-744. PubMed ID: 30746867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive Improvement with Glutathione Supplement in Alzheimer's Disease: A Way Forward.
    Mandal PK; Shukla D; Tripathi M; Ersland L
    J Alzheimers Dis; 2019; 68(2):531-535. PubMed ID: 30776003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.